NasdaqGM - Nasdaq Real Time Price USD

TransMedics Group, Inc. (TMDX)

92.08 +2.83 (+3.17%)
At close: April 26 at 4:00 PM EDT
92.11 +0.03 (+0.03%)
After hours: April 26 at 7:47 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
241,623.00
241,623.00
93,459.00
30,262.00
25,639.00
Cost of Revenue
87,530.00
87,530.00
28,187.00
9,103.00
9,004.00
Gross Profit
154,093.00
154,093.00
65,272.00
21,159.00
16,635.00
Operating Expense
182,820.00
182,820.00
96,709.00
60,587.00
43,019.00
Operating Income
-28,727.00
-28,727.00
-31,437.00
-39,428.00
-26,384.00
Net Non Operating Interest Income Expense
1,709.00
1,709.00
-2,826.00
-3,874.00
-3,985.00
Other Income Expense
347.00
347.00
-1,902.00
-877.00
1,653.00
Pretax Income
-26,671.00
-26,671.00
-36,165.00
-44,179.00
-28,716.00
Tax Provision
-1,643.00
-1,643.00
66.00
36.00
32.00
Net Income Common Stockholders
-25,028.00
-25,028.00
-36,231.00
-44,215.00
-28,748.00
Diluted NI Available to Com Stockholders
-25,028.00
-25,028.00
-36,231.00
-44,215.00
-28,748.00
Basic EPS
-0.77
-0.77
-1.23
-1.60
-1.16
Diluted EPS
-0.77
-0.77
-1.23
-1.60
-1.16
Basic Average Shares
32,517.37
32,517.37
29,556.63
27,616.84
24,702.76
Diluted Average Shares
32,517.37
32,517.37
29,556.63
27,616.84
24,702.76
Total Operating Income as Reported
-28,727.00
-28,727.00
-31,437.00
-39,428.00
-26,384.00
Total Expenses
270,350.00
270,350.00
124,896.00
69,690.00
52,023.00
Net Income from Continuing & Discontinued Operation
-25,028.00
-25,028.00
-36,231.00
-44,215.00
-28,748.00
Normalized Income
-25,309.40
-25,309.40
-34,730.00
-44,215.00
-28,748.00
Interest Income
12,500.00
12,500.00
900.00
--
--
Interest Expense
10,791.00
10,791.00
3,726.00
3,874.00
3,985.00
Net Interest Income
1,709.00
1,709.00
-2,826.00
-3,874.00
-3,985.00
EBIT
-15,880.00
-15,880.00
-32,439.00
-40,305.00
-24,731.00
EBITDA
-7,703.00
-7,703.00
-28,961.00
-38,488.00
-23,154.00
Reconciled Cost of Revenue
87,530.00
87,530.00
28,187.00
9,103.00
9,004.00
Reconciled Depreciation
8,177.00
8,177.00
3,478.00
1,817.00
1,577.00
Net Income from Continuing Operation Net Minority Interest
-25,028.00
-25,028.00
-36,231.00
-44,215.00
-28,748.00
Total Unusual Items Excluding Goodwill
300.00
300.00
-1,900.00
--
--
Total Unusual Items
300.00
300.00
-1,900.00
--
--
Normalized EBITDA
-8,003.00
-8,003.00
-27,061.00
-38,488.00
-23,154.00
Tax Rate for Calcs
0.00
0.00
0.00
--
0.00
Tax Effect of Unusual Items
18.60
18.60
-399.00
--
--
12/31/2020 - 5/2/2019

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

INMD InMode Ltd.
17.14
+0.71%
 
SWAV Shockwave Medical, Inc.
330.00
+0.31%
 
NARI Inari Medical, Inc.
38.42
+0.92%
 
DXCM DexCom, Inc.
124.34
-9.91%
 
ALGN Align Technology, Inc.
309.02
-0.48%
 
INSP Inspire Medical Systems, Inc.
237.45
+2.79%
 
CLPT ClearPoint Neuro, Inc.
5.26
-0.94%
 
PODD Insulet Corporation
166.19
+1.23%
 
BSX Boston Scientific Corporation
73.17
-0.12%
 
OM Outset Medical, Inc.
2.4000
+0.84%